Keywords: Sanofi, Finanial results, Fourth-quarter and full-year 2012

Sanofi 4th-qtr earnings slump but still beat expectations; expects growth to resume in 2013

Article | 07 February 2013

Print This

Shares of French pharma major Sanofi (Euronext: SAN) dropped nearly 4% to 66.67 euros in early trading this morning, as the company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in